A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)

NCT00565292 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Hyperlipidemia

Interventions

DRUG: MK0859

Sponsor

Merck Sharp & Dohme LLC